Risk factors for oxygen requirement in hospitalized pregnant and postpartum women with COVID-19

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA
Citação
CLINICS, v.77, article ID 100072, 6p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To identify risk factors for Oxygen (O-2) needs in pregnant and postpartum women with COVID-19. Methods: Prospective cohort involving pregnant women hospitalized with COVID-19 from April to October 2020. The oxygen need was analyzed regarding risk factors: demographic characteristics, clinical and laboratory parameters at hospital admission, and chest Computer Tomography (CT) findings. Poisson univariate analysis was used to estimate the Relative Risk (RR) and 95% Confidence Intervals. Results: 145 patients, 80 who used and 65 who did not use O-2, were included. Body mass index >= 30, smoking, and chronic hypertension increased the risk of O-2 need by 1.86 (95% CI 1.10-3.21), 1.57 (95% CI 1.16-2.12), and 1.46 (95% CI 1.09-1.95), respectively. Patients who were hospitalized for COVID-19 and for obstetric reasons had 8.24 (95% CI 2.8-24.29) and 3.44 (95% CI 1.05-11.31) times more use of O-2 than those admitted for childbirth and abortion. Respiratory rate >= 24 breaths/min and O-2 saturation < 95% presented RR for O-2 requirements of 2.55 (1.82-3.56) and 1.68 (95% CI 1.27-2.20), respectively. Ground Glass (GG) < 50% and with GG >= 50%, the risk of O-2 use were respectively 3.41-fold and 5.33-fold higher than in patients who haven't viral pneumonia on CT. The combination of C-reactive protein >= 21 mg/L, hemoglobin < 11.0 g/dL, and lymphopenia < 1500 mm(3) on hospital admission increased the risk of O-2 use by 4.97-times. Conclusions: In obstetric patients, clinical history, laboratory, clinical and radiological parameters at admission were identified as a risk for O-2 need, selecting the population with the greatest chance of worsening.
Palavras-chave
COVID-19, Risk factors, Pregnancy, Maternal mortality, Oxygen supply, Intensive care unit, Severe acute respiratory syndrome
Referências
  1. Altman E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155328
  2. [Anonymous], 2021, MANUAL RECOMENDACOES, V2
  3. DeBolt CA, 2021, AM J OBSTET GYNECOL, V224, DOI 10.1016/j.ajog.2020.11.022
  4. Feng XD, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00301
  5. Fu JH, 2020, THROMB RES, V192, P3, DOI 10.1016/j.thromres.2020.05.006
  6. Heldt FS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83784-y
  7. Hessami K, 2022, J MATERN-FETAL NEO M, V35, P2936, DOI 10.1080/14767058.2020.1806817
  8. Huang I, 2020, THER ADV RESPIR DIS, V14, DOI 10.1177/1753466620937175
  9. Joseph NT, 2020, BJOG-INT J OBSTET GY, V127, P1627, DOI 10.1111/1471-0528.16521
  10. La Verde M, 2021, INT J GYNECOL OBSTET, V154, P212, DOI 10.1002/ijgo.13726
  11. Latz CA, 2020, ANN HEMATOL, V99, P2113, DOI 10.1007/s00277-020-04169-1
  12. Liu F, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104370
  13. Lokken EM, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.05.031
  14. Martinez-Portilla RJ, 2021, ULTRASOUND OBST GYN, V57, P224, DOI 10.1002/uog.23575
  15. Nakamura-Pereira M, 2021, INT J GYNECOL OBSTET, V153, P360, DOI 10.1002/ijgo.13643
  16. Pacheco LD, 2020, OBSTET GYNECOL, V136, P42, DOI [10.1097/A0G0000000000003929, 10.1097/AOG.0000000000003929]
  17. Pan F, 2020, INT J MED SCI, V17, P1281, DOI 10.7150/ijms.46614
  18. Pierce-Williams RAM, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100134
  19. Qeadan F, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03772-y
  20. San-Juan R, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100407
  21. Savasi VM, 2020, OBSTET GYNECOL, V136, P252, DOI 10.1097/AOG.0000000000003979
  22. Francisco RPV, 2021, CLINICS, V76, DOI 10.6061/clinics/2021/e3120
  23. Wang HZ, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106683
  24. Yap M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-041868
  25. Zambrano LD, 2020, MMWR-MORBID MORTAL W, V69, P1641, DOI 10.15585/mmwr.mm6944e3
  26. Zhang YJ, 2021, ANN HEMATOL, V100, P1123, DOI 10.1007/s00277-021-04489-w